Breaking the Code: New Hope for Triple Negative Breast Cancer
Triple negative breast cancer (TNBC) is a challenging type of breast cancer. It's tough to treat because it doesn't respond well to targeted therapies. This is partly due to changes in certain signaling pathways, like the PI3K and mTOR pathways. Researchers have found that a protein called RICTOR plays a big role. When RICTOR is overactive, it makes TNBC mor...